The biological material carries measurable markers that reflect either the pathogen or the host response. Depending on the sample, laboratory assays can identify pathogen nucleic acids, antigens, antibodies, proteins, or host cells. Detecting these different marker classes allows researchers to investigate infection directly while also assessing immune activation and inflammation.
Different materials can provide access to different biological signals. Saliva, urine, stool, exhaled breath, and surface secretions may contain pathogen or host-response markers, but the useful targets depend on what is present in each specimen. Selecting an appropriate source therefore influences whether a study can assess infection, antibody responses, inflammation, or other outcomes.
Repeated collection supports longitudinal analysis, meaning researchers can compare measurements from the same study period across disease progression, treatment response, transmission, and recovery. Because these approaches reduce collection burden, they can be useful when frequent blood or tissue sampling is impractical. The resulting time series may show changing pathogen or immune-response markers.
The workflow begins with collecting a biological material such as saliva, urine, stool, exhaled breath, or a surface secretion. Researchers then use laboratory assays to isolate relevant material and detect selected markers, including nucleic acids, antigens, antibodies, proteins, or host cells. The detected signals are subsequently interpreted in relation to infection or immune activity.
Researchers may select this approach when blood or tissue collection is impractical, uncomfortable, or difficult to repeat. Its lower burden can support screening, diagnosis, pathogen surveillance, and studies requiring serial measurements. It also reduces exposure risks associated with collection, making it useful when investigators need to monitor participants over time.
In this field, researchers use collected specimens to examine both infectious agents and host responses. Assays may support screening or diagnosis by detecting pathogen markers, while surveillance studies track pathogen presence across samples. Other analyses measure inflammation or antibody responses, helping characterize disease progression, treatment response, transmission, and recovery.